The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma
/in Dendritic Cells, International Publications, Prostate Cancer /von 2016-12-20 / J Immunother Cancer 2016;4:92Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2 DCIS Independent of Route: Results of Randomized Selection Design Trial
/in Breast Cancer, Dendritic Cells, International Publications /von 2016-12-13 / Clin Cancer Res 2017 Jun;23(12):2961-2971Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions
/in Acute Leukemia, Dendritic Cells, International Publications /von 2016-12-07 / Sci Transl Med 2016 12;8(368):368ra171Emerging role of immunotherapy in urothelial carcinoma-Advanced disease
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Urothelial Carcinoma /von 2016-12-01 / Urol Oncol 2016 12;34(12):538-547Dendritic cell vaccines for melanoma: past, present and future
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-11-29 / Melanoma Manag 2016 Dec;3(4):273-289Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2016-11-23 / Exp. Hematol. 2017 Feb;46:48-55Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2016-11-14 / Bone Marrow Transplant. 2017 Feb;52(2):228-237Novel vaccines for glioblastoma: clinical update and perspective
/in Dendritic Cells, Glioblastoma, International Publications /von 2016-11-01 / Immunotherapy 2016 11;8(11):1293-1308Dendritic Cells and Cancer Immunity
/in Dendritic Cells, International Publications /von 2016-10-25 / Trends Immunol. 2016 12;37(12):855-865
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de